London Calling 2026 - Speakers
Speakers
Check out the line up of speakers at London Calling 2026.
Oxford Nanopore Technologies
Mikhail Kolmogorov
- Job title
- Institution
- National Cancer Institute, USA
- Biography
Mikhail Kolmogorov is currently a tenure-track Stadtman Investigator at the National Cancer Institute, where he leads a group focusing on computational and cancer genomics. Prior to that Mikhail was a postdoctoral fellow at the University of California Santa Cruz, supervised by Dr Benedict Paten. He completed his PhD in September 2019 in Computer Science from University California San Diego, under the mentorship of Dr Pavel Pevzner. Mikhail received his M.S. in bioinformatics from St. Petersburg Academic University, Russia.
- Recent publications
Keskus, A.G. et al. Severus detects somatic structural variation and complex rearrangements in cancer genomes using long-read sequencing. Nat. Biotechnol. 44, 247–257 (2026).
DOI: 10.1038/s41587-025-02618-8Ahmad, T. et al. Wakhan: reconstruction of chromosome-scale copy number profiles of tumor genomes with long-read sequencing. medRxiv 25342098 (2025).
DOI: 10.64898/2025.12.11.25342098Park, J. et al Accurate somatic small variant discovery for multiple sequencing technologies with DeepSomatic. Nat. Biotechnol. (2025).
DOI: 10.1038/s41587-025-02839-x
Talks at this conference
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.
